Claritev EPS - Earnings per Share 2019-2025 | CTEV

Claritev eps - earnings per share from 2019 to 2025. Eps - earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.
Claritev Annual EPS
2024 $-101.92
2023 $-5.69
2022 $-36.00
2021 $6.40
2020 $-44.40
2019 $0.80
2018 $3.60
Claritev Quarterly EPS
2025-03-31 $-4.38
2024-12-31 $-8.67
2024-09-30 $-24.25
2024-06-30 $-35.60
2024-03-31 $-33.40
2023-12-31 $-1.80
2023-09-30 $-1.49
2023-06-30 $-2.40
2023-03-31 $0.00
2022-12-31 $-40.80
2022-09-30 $1.20
2022-06-30 $0.80
2022-03-31 $2.80
2021-12-31 $1.60
2021-09-30 $4.80
2021-06-30 $-2.80
2021-03-31 $2.80
2020-12-31 $-10.80
2020-09-30 $-27.60
2020-06-30 $-5.60
2020-03-31 $-0.40
2019-12-31 $0.00
2018-12-31 $0.00
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.452B $0.931B
Claritev Corporation is a healthcare technology, data and insights company. Claritev Corporation, formerly known as MultiPlan, is based in NEW YORK.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $38.988B 53.85
Hims & Hers Health (HIMS) United States $13.954B 144.98
Tempus AI (TEM) United States $10.977B 0.00
IRhythm Technologies (IRTC) United States $4.526B 0.00
Inspire Medical Systems (INSP) United States $4.418B 69.02
Privia Health (PRVA) United States $3.048B 208.33
Enovis (ENOV) United States $2.027B 11.30
Clover Health Investments (CLOV) United States $1.832B 0.00
Schrodinger (SDGR) United States $1.721B 0.00
Phreesia (PHR) United States $1.510B 0.00
Omnicell (OMCL) United States $1.305B 23.02
Azenta (AZTA) United States $1.242B 57.70
10x Genomics (TXG) United States $1.100B 0.00
Fulgent Genetics (FLGT) United States $0.646B 0.00
Butterfly Network (BFLY) United States $0.574B 0.00
Talkspace (TALK) United States $0.504B 150.50
Veradigm (MDRX) United States $0.476B 0.00
Standard BioTools (LAB) United States $0.399B 0.00
TruBridge (TBRG) United States $0.376B 834.00
Health Catalyst (HCAT) United States $0.271B 0.00
Nyxoah SA (NYXH) Belgium $0.231B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.191B 0.00
EUDA Health Holdings (EUDA) Singapore $0.144B 0.00
Pulmonx (LUNG) United States $0.134B 0.00
American Well (AMWL) United States $0.114B 0.00
MDxHealth SA (MDXH) Belgium $0.098B 0.00
CareCloud (CCLD) United States $0.088B 3.34
Outset Medical (OM) United States $0.070B 0.00
111 (YI) China $0.068B 0.00
Retrieve Medical Holdings (RMHI) United States $0.059B 0.00
P3 Health Partners (PIII) United States $0.057B 0.00
HeartBeam (BEAT) United States $0.055B 0.00
Zepp Health (ZEPP) Netherlands $0.041B 0.00
Zhongchao (ZCMD) China $0.032B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.022B 0.00
Bullfrog AI Holdings (BFRG) United States $0.016B 0.00
MSP Recovery (MSPR) United States $0.013B 0.00
Precipio (PRPO) United States $0.013B 0.00
Strata Skin Sciences (SSKN) United States $0.010B 0.00
Streamline Health Solutions (STRM) United States $0.010B 0.00
Predictive Oncology (POAI) United States $0.009B 0.00
Movano (MOVE) United States $0.006B 0.00
HeartSciences (HSCS) United States $0.004B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.004B 0.00
Tivic Health Systems (TIVC) United States $0.004B 0.00
Healthcare Triangle (HCTI) United States $0.000B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00